DEJOURA Trademark

Trademark Overview

On Tuesday, December 18, 2018, a trademark application was filed for DEJOURA with the United States Patent and Trademark Office. The USPTO has given the DEJOURA trademark a serial number of 88232855. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The DEJOURA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of acne
dejoura

General Information

Serial Number88232855
Word MarkDEJOURA
Filing DateTuesday, December 18, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of acne

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, December 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 23, 2021SOU EXTENSION 5 GRANTED
Monday, December 13, 2021SOU EXTENSION 5 FILED
Thursday, December 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 13, 2021TEAS EXTENSION RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 4 GRANTED
Thursday, June 17, 2021SOU EXTENSION 4 FILED
Thursday, June 17, 2021TEAS EXTENSION RECEIVED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 16, 2020SOU EXTENSION 3 GRANTED
Wednesday, December 16, 2020SOU EXTENSION 3 FILED
Wednesday, December 16, 2020TEAS EXTENSION RECEIVED
Saturday, June 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 11, 2020SOU EXTENSION 2 GRANTED
Thursday, June 11, 2020SOU EXTENSION 2 FILED
Thursday, June 11, 2020TEAS EXTENSION RECEIVED
Saturday, December 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2019SOU EXTENSION 1 GRANTED
Thursday, December 12, 2019SOU EXTENSION 1 FILED
Thursday, December 12, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019ASSIGNED TO EXAMINER
Wednesday, January 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 21, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dejoura acne treatment preparations pharmaceutical